Geneva Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.95M | Buy |
21,507
+35
| +0.2% | +$3.18K | 0.03% | 222 |
|
|
2017
Q1 | $1.89M | Sell |
21,472
-2,514
| -10% | -$221K | 0.03% | 221 |
|
|
2016
Q4 | $1.99M | Buy |
23,986
+419
| +2% | +$34.7K | 0.04% | 209 |
|
|
2016
Q3 | $2.18M | Hold |
23,567
| – | – | 0.04% | 186 |
|
|
2016
Q2 | $1.83M | Sell |
23,567
-7,745
| -25% | -$603K | 0.04% | 209 |
|
|
2016
Q1 | $2.58M | Buy |
31,312
+8,560
| +38% | +$706K | 0.05% | 157 |
|
|
2015
Q4 | $2.38M | Sell |
22,752
-105
| -0.5% | -$11K | 0.05% | 178 |
|
|
2015
Q3 | $2.41M | Sell |
22,857
-7,080
| -24% | -$746K | 0.05% | 168 |
|
|
2015
Q2 | $4.1M | Sell |
29,937
-595
| -2% | -$81.4K | 0.07% | 145 |
|
|
2015
Q1 | $3.81M | Buy |
30,532
+7,310
| +31% | +$911K | 0.07% | 149 |
|
|
2014
Q4 | $2.1M | Buy |
23,222
+1,935
| +9% | +$175K | 0.04% | 192 |
|
|
2014
Q3 | $1.54M | Buy |
21,287
+1,255
| +6% | +$90.6K | 0.03% | 233 |
|
|
2014
Q2 | $1.25M | Buy |
20,032
+1,900
| +10% | +$118K | 0.02% | 280 |
|
|
2014
Q1 | $1.24M | Buy |
18,132
+742
| +4% | +$50.6K | 0.02% | 273 |
|
|
2013
Q4 | $1.22M | Sell |
17,390
-194,736
| -92% | -$13.7M | 0.02% | 232 |
|
|
2013
Q3 | $15.3M | Buy |
212,126
+195,946
| +1,211% | +$14.1M | 0.32% | 85 |
|
|
2013
Q2 | $902K | Buy |
+16,180
| New | +$902K | 0.02% | 227 |
|